Spondyloarthritis & psoriatic arthritis
The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis
Authors' conclusion
The findings suggest a high prevalence of sarcopenia in SpA patients
Study context
- Population
- Patients with spondyloarthritis (SpA) in studies published up to 2023 (EMBASE, MEDLINE, Web of Science, Cochrane)
- Participants
- 999 patients16 studies
- Outcome
- Overall prevalence of sarcopenia in SpA
Methodological detailsrandom-effects model
- Random-effects model
Pooled result
As reported in the abstract
Prevalence of sarcopenia
SpA
25.0%
95% CI 0.127–0.352
Further pooled results
| Outcome | Values |
|---|---|
| Prevalence of presarcopenia | SpA 21.0% |
| Prevalence of severe sarcopenia | SpA 8.7% |
Original publication
The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis. Arthritis Res Ther. Published 16 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →